Zion Market Research has published a new report titled “Fluorescence In Situ Hybridization Probe Market by Type (DNA, and RNA [mRNA, miRNA, and Other]), by Technology (Q FISH, FLOW FISH, and Others), by Application (Cancer Research [Lung, Breast, Bladder, Blood, Prostrate, Cervical, Others], Genetic Diseases, and Others), and by End User (Research & Academic Institutes, Diagnostic Centers, and Others): Global Industry Perspective, Comprehensive Analysis and Forecast, 2019 – 2025”. According to the report, global demand for fluorescence in situ hybridization probe market was valued at approximately USD 668.7 million in 2018, and is expected to generate revenue of USD 1,079.0 million by end of 2025, growing at a CAGR of 7.1% between 2019 and 2025.
Get Access to the FREE sample report @ https://www.zionmarketresearch.com/sample/fluorescence-in-situ-hybridization-probe-market
Fluorescent in situ hybridization (FISH) technique has wide range of applications in diagnostics industry like therapeutic drug monitoring, characterization of marker chromosomes, identification of structural and numerical abnormalities in the chromosomes, and rare genetic disease identification. FISH is also used in molecular cytogenetic technique that uses fluorescent probes to map and visualize individual’s genetic material. This technique is used to identify the fluorescent probes bound to the chromosome. Also, this technique has numerous applications in clinical research like characterization of somatic cell hybrids and gene mapping.
Increasing prevalence rate of diseases that have cytogenetic base like genetic abnormalities, cancer along with demand for accurate, sensitive, and rapid prognosis techniques for validation of diseases are some of the factors boosting market growth for FISH probes. Moreover, research and development activities by various market players for the development of new disease-specific biomarkers and rising pipeline products awaiting regulatory approval are also attributing to the market growth of FISH probes globally. Likely, development of new and advanced probes and rising awareness with growing healthcare expenditure is also likely to drive the market growth.
The fluorescence in situ hybridization probe market is segmented based on application, type, technology, end user, and regions. On the basis of type the market is segmented into RNA, and DNA. The segment for RNA is further bifurcated into miRNA, mRNA, and other. The segment for mRNA held major share of the market owing to the growing demand of molecular profiling by the healthcare professionals. Moreover, technically sound molecular pathology devices are also helping in the stratification for appropriate treatment which is further contributing to the overall demand and segmental growth. On the basis of technology the market is segmented into FLOW FISH, Q FISH, and others. The segment for Q FISH technique is likely to showcase high growth rate in the forecast period as these are commonly used to study instabilities in genome and also offer many advantages like high affinity for telomeric repeats thus contributing in the overall market growth of this segment.
On the basis of application the market is segmented into genetic diseases, cancer research, and others. The segment for cancer research is further bifurcated into breast, lung, bladder, prostrate, blood, cervical, others. The segment for cancer research held major share of the market. Rising prevalence of cancer across the globe and demand for sensitive, rapid, and accurate molecular diagnostic tests are some of the factors boosting market growth of this segment. Likely, FISH probes are also widely used in diagnosis of detection cancer like lung, and breast cancers. The end user market is segmented into diagnostic centers, research & academic institutes, and others. The segment for diagnostic centers is likely to grow at high CAGR in the forecast period.
The regional segmentation includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America, and Middle East & Africa with its further bifurcation into major countries. North America held dominant position of the market in 2018 owing to the high adoption rate of advanced diagnostic techniques and growing burden of infectious diseases and cancer. The growing prevalence of genetic disorders, breast cancer, and birth defects the adoption rate of FISH probes in the diagnosis has raised thus boosting the market growth in this region.
Some of the players in the market for fluorescence in situ hybridization probe include Biocare Medical, LLC, PerkinElmer Inc., F. Hoffmann-La Roche AG, Life Science Technologies, Abnova Corporation, Abbott Laboratories, Oxford Gene Technologies, Genemed Biotechnologies, Inc., Biosearch Technologies, Inc., and Agilent Technologies.
This report segments the global fluorescence in situ hybridization probe market as follows:
Global Fluorescence In Situ Hybridization Probe Market: Type Segment Analysis
Global Fluorescence In Situ Hybridization Probe Market: Technology Segment Analysis
Global Fluorescence In Situ Hybridization Probe Market: Application Segment Analysis
Global Fluorescence In Situ Hybridization Probe Market: End User Segment Analysis
Global Fluorescence In Situ Hybridization Probe Market: Regional Segment Analysis
To view TOC of this report is available upon request @ https://www.zionmarketresearch.com/toc/fluorescence-in-situ-hybridization-probe-market